Skip to main content

Table 1 Patients’ characteristics

From: Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~

 

RS

FSS

P-value*

 

N

%

N

%

 

Total

184

 

101

  

Age (median/mean/SD)

41/40.3/4.3

33/32.0/7.6

< 0.0001

FIGO stage

 IA

66

35.9

43

42.6

0.3004#1

 IB

2

1.1

0

0.0

 

 IC1

74

40.2

43

42.6

 

 IC2/IC3

42

22.8

15

14.9

 

Histological type

 Clear-cell

73

39.7

22

21.8

< 0.0001

 Mucinous

38

20.7

51

50.5

 

 Endometrioid

54

29.3

24

23.8

 

 Serous

15

8.2

3

3.0

 

 Mix

3

1.6

0

0.0

 

 Others#1

1

0.5

1

1.0

 

Grade

 G1/G2

106

57.6

79

78.2

0.0005

 G3/Clear-cell

78

42.4

22

21.8

 

CA125

  ≤ 35 U/mL

71

38.6

48

47.5

0.143

  > 35 U/mL

113

61.4

53

52.5

 

Ascites volume

  ≤ 100 mL

156

84.8

87

86.1

0.757

  > 100 mL

28

15.2

14

13.9

 

Ascites cytology

 Negative

159

86.4

94

93.1

0.0887

 Positive

25

13.6

7

6.9

 

Chemotherapy

 Absent

34

18.5

37

36.6

0.0007

 Present

150

81.5

64

63.4

 
  1. FIGO Internatinal Federation of Gynecology and Obstetrics, #1: IA vs. IB vs. IC
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us